首页> 外文期刊>Journal of clinical psychopharmacology >Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder
【24h】

Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder

机译:帕潘立酮棕榈酸酯和奥氮平棕榈酸酯联合治疗耐药性分裂情感障碍的疗效和安全性

获取原文
获取原文并翻译 | 示例
           

摘要

The patient was a 51-year-old white French man who met the Diagnostic and Statistical Manual of Mental Disorders (DSM 5) criteria for resistant schizoaffective disorder (bipolar type with continuous following course). He presented with agitation and expensive mood with mood-congruent delusions (persecution, megalomania, and mystical experiences). These symptoms were associated with auditory hallucinations and disorganized speech. Initial diagnosis was established in 1982. Owing to the severity of his disorder, he had been an inpatient since 2001.
机译:该患者是一名51岁的法国白人,他符合精神分裂症/情感障碍性疾病(双极型,持续进行疗程)的精神疾病诊断和统计手册(DSM 5)标准。他表现出激动和昂贵的情绪,以及情绪一致的妄想(逼迫,大妄想和神秘经历)。这些症状与幻听和言语混乱有关。最初的诊断始于1982年。由于疾病的严重性,他从2001年开始住院。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号